Dec 03, 2014 8:30am EST SCYNEXIS, Inc. Announces Appointment of Two Seasoned Industry Professionals to Its Board of Directors
Nov 03, 2014 8:35am EST SCYNEXIS, Inc. Enters Into Worldwide Agreement With Waterstone Pharmaceutical for the Development and Commercialization of SCY-635 for Viral Diseases
Jun 16, 2014 8:30am EDT SCYNEXIS Provides Update on Corporate Progress and First Quarter 2014 Financial Results
